Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Cumberland Pharmaceuticals Inc CPIX

Healthcare
Cumberland Pharmaceuticals Inc. is a specialty pharmaceutical company. The Company is focused on the acquisition, development and commercialization of branded prescription pharmaceutical products. Its portfolio of brands includes Acetadote injection, for the treatment of acetaminophen poisoning; Caldolor injection, for the treatment of pain and fever, Kristalose for oral solution, a... see more

Recent & Breaking News (NDAQ:CPIX)

Cumberland Pharmaceuticals Reports 9% Revenue Growth In 2020

PR Newswire March 9, 2021

Cumberland Pharmaceuticals To Announce Fourth Quarter And Annual 2020 Financial Results

PR Newswire March 2, 2021

Introducing RediTrex®, A New Methotrexate Delivery System

PR Newswire November 17, 2020

Cumberland Pharmaceuticals Reports Third Quarter 2020 Financial Results & Company Update

PR Newswire November 10, 2020

Cumberland Pharmaceuticals To Announce Third Quarter 2020 Financial Results

PR Newswire November 3, 2020

Newly Published Literature Supports Use Of Caldolor® For Postoperative Pain And Reduction Of Opioid Use

PR Newswire August 18, 2020

Cumberland Pharmaceuticals Reports Second Quarter 2020 Financial Results & Company Update

PR Newswire August 11, 2020

Cumberland Pharmaceuticals To Announce Second Quarter 2020 Financial Results

PR Newswire August 4, 2020

Caldolor® Demonstrates Significant Reduction Of Opioid Use In Orthopedic Trauma Patients

PR Newswire July 20, 2020

New Publication Reveals Real-World Usage of Vibativ® In Patients With Bacteremia Or Endocarditis

PR Newswire May 26, 2020

Cumberland Pharmaceuticals Reports First Quarter 2020 Financial Results & Company Update

PR Newswire May 20, 2020

Cumberland Pharmaceuticals To Announce First Quarter 2020 Financial Results

PR Newswire May 15, 2020

Vibativ® Sustained Potency Confirmed In Two Surveillance Studies

PR Newswire May 11, 2020

Cumberland Pharmaceuticals Releases Inaugural Report On Its Environmental, Social And Governance (ESG) Activities

PR Newswire April 28, 2020

To Help Prepare for the COVID-19 Patient Surge Cumberland Pharmaceuticals Expands Availability of Vaprisol® to Treat Hyponatremia in Critical Care Units

PR Newswire April 7, 2020

Cumberland Pharmaceuticals Announces Initiative to Expand Availability of Caldolor® to Help Treat High Fevers Associated With Coronavirus Infections

PR Newswire March 31, 2020

Cumberland Pharmaceuticals Announces Initiative To Expand Availability Of VIBATIV® To Treat Hospital-Acquired & Ventilator-Associated Pneumonia Resulting From Coronavirus Infections

PR Newswire March 23, 2020

Cumberland Pharmaceuticals Reports 17% Revenue Growth For The Full Year 2019

PR Newswire March 18, 2020

Caldolor® Demonstrates Favorable Safety Profile In Newborns

PR Newswire March 17, 2020

Cumberland Pharmaceuticals Reschedules Fourth Quarter And Annual 2019 Financial Results

PR Newswire March 6, 2020